End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation
A series of tubes: The continuous manufacture of a finished drug product starting from chemical intermediates is reported. The continuous pilot‐scale plant used a novel route that incorporated many advantages of continuous‐flow processes to produce active pharmaceutical ingredients and the drug prod...
Gespeichert in:
| Veröffentlicht in: | Angewandte Chemie International Edition 2013-11, Vol.52 (47), p.12359-12363 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 12363 |
|---|---|
| container_issue | 47 |
| container_start_page | 12359 |
| container_title | Angewandte Chemie International Edition |
| container_volume | 52 |
| creator | Mascia, Salvatore Heider, Patrick L. Zhang, Haitao Lakerveld, Richard Benyahia, Brahim Barton, Paul I. Braatz, Richard D. Cooney, Charles L. Evans, James M. B. Jamison, Timothy F. Jensen, Klavs F. Myerson, Allan S. Trout, Bernhardt L. |
| description | A series of tubes: The continuous manufacture of a finished drug product starting from chemical intermediates is reported. The continuous pilot‐scale plant used a novel route that incorporated many advantages of continuous‐flow processes to produce active pharmaceutical ingredients and the drug product in one integrated system. |
| doi_str_mv | 10.1002/anie.201305429 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1701115691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1458504113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5879-b31b58c7dc065e4c07de44bfb0d2c71b2032ac0b801a831cacbcc4690cc0bb13</originalsourceid><addsrcrecordid>eNqNkc9v0zAYhiMEYmPjyhFZ4rLDUvwjjh1uU2m3TqUMbRK9WbbjdB6pPWwH6H8_l44KcRknW_bzPtL3vUXxBsERghC_l86aEYaIQFrh5llxiChGJWGMPM_3ipCScYoOilcx3mWec1i_LA5whRAllB4WPyauLZMv8wHG3iXrBj9E8Em6oZM6DcG6FfAduLqVYS21GZLVso8fwMwlswoymRZcb1y6NdHGU3CVA10mkvXuFMgsnVone_DRR7kyYOqzZPt3XLzossa8fjyPipvp5GZ8Uc4_n8_GZ_NSU86aUhGkKNes1bCmptKQtaaqVKdgizVDCkOCpYaKQyQ5QVpqpXVVN1DnR4XIUXGy094H_30wMYm1jdr0vXQmjykQgyhvom7-A60opzDvjWT03T_onR9CHvM3BSHHiONMjXaUDj7GYDpxH-xaho1AUGy7E9vuxL67HHj7qB3U2rR7_E9ZGWh2wE_bm80TOnG2mE3-lpe7rI3J_NpnZfgmakYYFV8X5-LL9WJ5Ob9ciiV5APGDtYY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1450082182</pqid></control><display><type>article</type><title>End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation</title><source>MEDLINE</source><source>Wiley Online Library</source><creator>Mascia, Salvatore ; Heider, Patrick L. ; Zhang, Haitao ; Lakerveld, Richard ; Benyahia, Brahim ; Barton, Paul I. ; Braatz, Richard D. ; Cooney, Charles L. ; Evans, James M. B. ; Jamison, Timothy F. ; Jensen, Klavs F. ; Myerson, Allan S. ; Trout, Bernhardt L.</creator><creatorcontrib>Mascia, Salvatore ; Heider, Patrick L. ; Zhang, Haitao ; Lakerveld, Richard ; Benyahia, Brahim ; Barton, Paul I. ; Braatz, Richard D. ; Cooney, Charles L. ; Evans, James M. B. ; Jamison, Timothy F. ; Jensen, Klavs F. ; Myerson, Allan S. ; Trout, Bernhardt L.</creatorcontrib><description>A series of tubes: The continuous manufacture of a finished drug product starting from chemical intermediates is reported. The continuous pilot‐scale plant used a novel route that incorporated many advantages of continuous‐flow processes to produce active pharmaceutical ingredients and the drug product in one integrated system.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.201305429</identifier><identifier>PMID: 24115355</identifier><identifier>CODEN: ACIEAY</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Acids - chemistry ; Amides - chemical synthesis ; Amides - chemistry ; Amides - isolation & purification ; Catalysis ; continuous processing ; Crystallization ; Dosage ; Drug Compounding ; Drugs ; flow chemistry ; Formations ; Fumarates - chemical synthesis ; Fumarates - chemistry ; Fumarates - isolation & purification ; Ingredients ; lactones ; Pharmaceutical Preparations - chemical synthesis ; Pharmaceutical Preparations - chemistry ; Pharmaceutical Preparations - isolation & purification ; Pharmaceuticals ; protecting groups ; Purification ; Synthesis ; synthetic methods ; Technology, Pharmaceutical ; Tubes</subject><ispartof>Angewandte Chemie International Edition, 2013-11, Vol.52 (47), p.12359-12363</ispartof><rights>Copyright © 2013 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><rights>Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5879-b31b58c7dc065e4c07de44bfb0d2c71b2032ac0b801a831cacbcc4690cc0bb13</citedby><cites>FETCH-LOGICAL-c5879-b31b58c7dc065e4c07de44bfb0d2c71b2032ac0b801a831cacbcc4690cc0bb13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.201305429$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.201305429$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24115355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mascia, Salvatore</creatorcontrib><creatorcontrib>Heider, Patrick L.</creatorcontrib><creatorcontrib>Zhang, Haitao</creatorcontrib><creatorcontrib>Lakerveld, Richard</creatorcontrib><creatorcontrib>Benyahia, Brahim</creatorcontrib><creatorcontrib>Barton, Paul I.</creatorcontrib><creatorcontrib>Braatz, Richard D.</creatorcontrib><creatorcontrib>Cooney, Charles L.</creatorcontrib><creatorcontrib>Evans, James M. B.</creatorcontrib><creatorcontrib>Jamison, Timothy F.</creatorcontrib><creatorcontrib>Jensen, Klavs F.</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><creatorcontrib>Trout, Bernhardt L.</creatorcontrib><title>End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation</title><title>Angewandte Chemie International Edition</title><addtitle>Angew. Chem. Int. Ed</addtitle><description>A series of tubes: The continuous manufacture of a finished drug product starting from chemical intermediates is reported. The continuous pilot‐scale plant used a novel route that incorporated many advantages of continuous‐flow processes to produce active pharmaceutical ingredients and the drug product in one integrated system.</description><subject>Acids - chemistry</subject><subject>Amides - chemical synthesis</subject><subject>Amides - chemistry</subject><subject>Amides - isolation & purification</subject><subject>Catalysis</subject><subject>continuous processing</subject><subject>Crystallization</subject><subject>Dosage</subject><subject>Drug Compounding</subject><subject>Drugs</subject><subject>flow chemistry</subject><subject>Formations</subject><subject>Fumarates - chemical synthesis</subject><subject>Fumarates - chemistry</subject><subject>Fumarates - isolation & purification</subject><subject>Ingredients</subject><subject>lactones</subject><subject>Pharmaceutical Preparations - chemical synthesis</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical Preparations - isolation & purification</subject><subject>Pharmaceuticals</subject><subject>protecting groups</subject><subject>Purification</subject><subject>Synthesis</subject><subject>synthetic methods</subject><subject>Technology, Pharmaceutical</subject><subject>Tubes</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9v0zAYhiMEYmPjyhFZ4rLDUvwjjh1uU2m3TqUMbRK9WbbjdB6pPWwH6H8_l44KcRknW_bzPtL3vUXxBsERghC_l86aEYaIQFrh5llxiChGJWGMPM_3ipCScYoOilcx3mWec1i_LA5whRAllB4WPyauLZMv8wHG3iXrBj9E8Em6oZM6DcG6FfAduLqVYS21GZLVso8fwMwlswoymRZcb1y6NdHGU3CVA10mkvXuFMgsnVone_DRR7kyYOqzZPt3XLzossa8fjyPipvp5GZ8Uc4_n8_GZ_NSU86aUhGkKNes1bCmptKQtaaqVKdgizVDCkOCpYaKQyQ5QVpqpXVVN1DnR4XIUXGy094H_30wMYm1jdr0vXQmjykQgyhvom7-A60opzDvjWT03T_onR9CHvM3BSHHiONMjXaUDj7GYDpxH-xaho1AUGy7E9vuxL67HHj7qB3U2rR7_E9ZGWh2wE_bm80TOnG2mE3-lpe7rI3J_NpnZfgmakYYFV8X5-LL9WJ5Ob9ciiV5APGDtYY</recordid><startdate>20131118</startdate><enddate>20131118</enddate><creator>Mascia, Salvatore</creator><creator>Heider, Patrick L.</creator><creator>Zhang, Haitao</creator><creator>Lakerveld, Richard</creator><creator>Benyahia, Brahim</creator><creator>Barton, Paul I.</creator><creator>Braatz, Richard D.</creator><creator>Cooney, Charles L.</creator><creator>Evans, James M. B.</creator><creator>Jamison, Timothy F.</creator><creator>Jensen, Klavs F.</creator><creator>Myerson, Allan S.</creator><creator>Trout, Bernhardt L.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><scope>7SR</scope><scope>7TB</scope><scope>8BQ</scope><scope>8FD</scope><scope>FR3</scope><scope>JG9</scope></search><sort><creationdate>20131118</creationdate><title>End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation</title><author>Mascia, Salvatore ; Heider, Patrick L. ; Zhang, Haitao ; Lakerveld, Richard ; Benyahia, Brahim ; Barton, Paul I. ; Braatz, Richard D. ; Cooney, Charles L. ; Evans, James M. B. ; Jamison, Timothy F. ; Jensen, Klavs F. ; Myerson, Allan S. ; Trout, Bernhardt L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5879-b31b58c7dc065e4c07de44bfb0d2c71b2032ac0b801a831cacbcc4690cc0bb13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acids - chemistry</topic><topic>Amides - chemical synthesis</topic><topic>Amides - chemistry</topic><topic>Amides - isolation & purification</topic><topic>Catalysis</topic><topic>continuous processing</topic><topic>Crystallization</topic><topic>Dosage</topic><topic>Drug Compounding</topic><topic>Drugs</topic><topic>flow chemistry</topic><topic>Formations</topic><topic>Fumarates - chemical synthesis</topic><topic>Fumarates - chemistry</topic><topic>Fumarates - isolation & purification</topic><topic>Ingredients</topic><topic>lactones</topic><topic>Pharmaceutical Preparations - chemical synthesis</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical Preparations - isolation & purification</topic><topic>Pharmaceuticals</topic><topic>protecting groups</topic><topic>Purification</topic><topic>Synthesis</topic><topic>synthetic methods</topic><topic>Technology, Pharmaceutical</topic><topic>Tubes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mascia, Salvatore</creatorcontrib><creatorcontrib>Heider, Patrick L.</creatorcontrib><creatorcontrib>Zhang, Haitao</creatorcontrib><creatorcontrib>Lakerveld, Richard</creatorcontrib><creatorcontrib>Benyahia, Brahim</creatorcontrib><creatorcontrib>Barton, Paul I.</creatorcontrib><creatorcontrib>Braatz, Richard D.</creatorcontrib><creatorcontrib>Cooney, Charles L.</creatorcontrib><creatorcontrib>Evans, James M. B.</creatorcontrib><creatorcontrib>Jamison, Timothy F.</creatorcontrib><creatorcontrib>Jensen, Klavs F.</creatorcontrib><creatorcontrib>Myerson, Allan S.</creatorcontrib><creatorcontrib>Trout, Bernhardt L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Engineered Materials Abstracts</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Materials Research Database</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mascia, Salvatore</au><au>Heider, Patrick L.</au><au>Zhang, Haitao</au><au>Lakerveld, Richard</au><au>Benyahia, Brahim</au><au>Barton, Paul I.</au><au>Braatz, Richard D.</au><au>Cooney, Charles L.</au><au>Evans, James M. B.</au><au>Jamison, Timothy F.</au><au>Jensen, Klavs F.</au><au>Myerson, Allan S.</au><au>Trout, Bernhardt L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew. Chem. Int. Ed</addtitle><date>2013-11-18</date><risdate>2013</risdate><volume>52</volume><issue>47</issue><spage>12359</spage><epage>12363</epage><pages>12359-12363</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><coden>ACIEAY</coden><abstract>A series of tubes: The continuous manufacture of a finished drug product starting from chemical intermediates is reported. The continuous pilot‐scale plant used a novel route that incorporated many advantages of continuous‐flow processes to produce active pharmaceutical ingredients and the drug product in one integrated system.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>24115355</pmid><doi>10.1002/anie.201305429</doi><tpages>5</tpages><edition>International ed. in English</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1433-7851 |
| ispartof | Angewandte Chemie International Edition, 2013-11, Vol.52 (47), p.12359-12363 |
| issn | 1433-7851 1521-3773 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1701115691 |
| source | MEDLINE; Wiley Online Library |
| subjects | Acids - chemistry Amides - chemical synthesis Amides - chemistry Amides - isolation & purification Catalysis continuous processing Crystallization Dosage Drug Compounding Drugs flow chemistry Formations Fumarates - chemical synthesis Fumarates - chemistry Fumarates - isolation & purification Ingredients lactones Pharmaceutical Preparations - chemical synthesis Pharmaceutical Preparations - chemistry Pharmaceutical Preparations - isolation & purification Pharmaceuticals protecting groups Purification Synthesis synthetic methods Technology, Pharmaceutical Tubes |
| title | End-to-End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=End-to-End%20Continuous%20Manufacturing%20of%20Pharmaceuticals:%20Integrated%20Synthesis,%20Purification,%20and%20Final%20Dosage%20Formation&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Mascia,%20Salvatore&rft.date=2013-11-18&rft.volume=52&rft.issue=47&rft.spage=12359&rft.epage=12363&rft.pages=12359-12363&rft.issn=1433-7851&rft.eissn=1521-3773&rft.coden=ACIEAY&rft_id=info:doi/10.1002/anie.201305429&rft_dat=%3Cproquest_cross%3E1458504113%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1450082182&rft_id=info:pmid/24115355&rfr_iscdi=true |